GNH USA

Europe — EMA

Levofree

GNH USA supplies Levofree (Levodropropizine), a peripheral antitussive for dry and non‑productive coughs. Request a quote for global supply worldwide.

Levodropropizine

Request sourcing

1
Pack/s

What is Levodropropizine?

Levodropropizine, the active ingredient in Levofree, is an antitussive presented as an oral formulation for oral use. It suppresses dry and non‑productive coughs by acting on peripheral sensory nerves in the respiratory tract.\n\nGNH India supplies Levofree as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Levodropropizine used for?

Levodropropizine is used to suppress cough by acting on peripheral sensory nerves in the respiratory tract.\n\n- Dry cough: reduces frequency and intensity of non‑productive cough episodes.\n- Non‑productive cough: alleviates irritation‑driven cough without producing sputum.\n- Cough associated with upper respiratory tract infections: helps control persistent cough during viral colds.

What are the side effects of Levodropropizine?

Levofree may cause adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Nausea\n- Dizziness\n- Headache\n- Dry mouth\n- Abdominal discomfort\n- Altered taste perception\n\nSerious or Rare Side Effects:\n- Allergic reactions such as rash, urticaria or angioedema\n- Hepatic enzyme elevation\n- Severe skin reactions (e.g., Stevens‑Johnson syndrome)\n- Anaphylaxis\n- Hematologic abnormalities such as neutropenia

What precautions apply to Levodropropizine?

Before prescribing Levofree, clinicians should consider several safety aspects.\n\n- Pregnancy: consult a healthcare professional; safety data are limited.\n- Breastfeeding: avoid unless benefits outweigh potential risks.\n- Renal impairment: dose may require adjustment in severe cases.\n- Elderly patients: monitor for increased sensitivity to side effects.\n- Drug interactions: review concomitant medications for potential additive effects.\n- Store at room temperature: keep in the original container, protect from moisture and light.

What does Levodropropizine interact with?

Levofree can interact with other medicines, requiring attention to avoid adverse outcomes.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inhibitors: may increase levodropropizine plasma concentrations.\n- Monoamine oxidase inhibitors: risk of additive central effects.\n\nModerate Interactions (Monitor Closely):\n- Other antitussives: may cause excessive cough suppression.\n- Bronchodilators: monitor respiratory status for unexpected changes.\n- Alcohol: may enhance dizziness or drowsiness.

Frequently asked questions

What is Levofree used for?+
Levofree contains levodropropizine, a peripheral antitussive indicated for the symptomatic relief of dry and non‑productive coughs. It works by reducing the cough reflex without depressing the central nervous system, making it suitable for patients who need cough control while remaining alert.
How does levodropropizine work?+
Levodropropizine acts on sensory nerve endings in the respiratory tract, blocking the activation of cough receptors. By inhibiting the peripheral afferent signals that trigger the cough reflex, it lowers the frequency and intensity of coughing without affecting central brain pathways.
What is the usual dose of Levofree?+
The appropriate dose of Levofree is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function and severity of cough. Exact dosing regimens are not disclosed here and should follow the prescriber’s instructions.
Is Levofree safe during pregnancy or breastfeeding?+
Safety data for levodropropizine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Levofree.
How do I order Levofree from GNH USA?+
To order Levofree, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Levofree compare with other cough suppressants?+
Levofree’s active ingredient, levodropropizine, is a peripheral antitussive, unlike central agents such as codeine that act on the brainstem. This peripheral action reduces the risk of sedation, dependence and respiratory depression, making Levofree a preferable option for patients who need cough relief without central side effects.
How should Levofree be stored and handled?+
Levofree should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and efficacy throughout its shelf life.
How is Levofree administered?+
Levofree is taken orally. The tablet or liquid (depending on the marketed form) should be swallowed with a glass of water, following the dosage instructions provided by the prescriber. It can be taken with or without food, unless otherwise advised.
What are the most serious risks to watch for with Levofree?+
Serious adverse reactions, although rare, include allergic responses such as rash, urticaria, angioedema, severe skin conditions like Stevens‑Johnson syndrome, hepatic enzyme elevations and hematologic abnormalities such as neutropenia. Patients should seek immediate medical attention if they experience any of these symptoms.
Who should not use Levofree?+
Levofree should be avoided in individuals with known hypersensitivity to levodropropizine or any excipients in the formulation. Patients with severe hepatic impairment or those taking contraindicated medications (e.g., strong CYP3A4 inhibitors) should not use the product without medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Levodropropizine
Route
Oral Use
Manufacturer
Teva B.V
Origin
EU

Related products